<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917446</url>
  </required_header>
  <id_info>
    <org_study_id>JS-1</org_study_id>
    <nct_id>NCT03917446</nct_id>
  </id_info>
  <brief_title>Volume Responsiveness Assesment After Propofol.</brief_title>
  <official_title>Prediction of Volume Responsiveness After Propofol Bolus Injection in the Intensive Care Unit (ICU) Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients in ICU who suffer from circulatory insufficiency, regardless
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 3, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in blood pressure values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in heart rate values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in cardiac output values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac index</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in cardiac index values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke volume</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in stroke volume values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke index</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in stroke index values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke volume variation</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in stroke volume variation values after propofol bolus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum left ventricular contractility (dPmax)</measure>
    <time_frame>10 minutes</time_frame>
    <description>Change in dPmax values after propofol bolus.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Circulatory Failure</condition>
  <condition>Fluid Volume Disorder</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Euvolaemic</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypovolaemic</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol bolus</intervention_name>
    <description>Each patient gets propofol bolus in three doses. 0.25 mg/kg, 0.5 mg/kg and 1 mg/kg. After each dose patient's blood pressure, heart rate and haemodynamic values calibrated with PICCO device (cardiac output, cardiac index, stroke index, stroke volume, stroke volume variation, dPmax) are recorded in 15 seconds intervals for 10 minutes.</description>
    <arm_group_label>Euvolaemic</arm_group_label>
    <arm_group_label>Hypovolaemic</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Mechanically ventilated ICU patients with heamodynamic instability aged above 18.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ICU patient Haemodynamically instable Mechanically ventilated

        Exclusion Criteria:

        Simultaneous propofol infusion Contraindications for propofol Atrial fibrillation Valvular
        malfunction Aortic stenosis Aortic aneurysm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan J Stefaniak, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Gdansk, Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan J Stefaniak, M.D.</last_name>
    <phone>+48583493270</phone>
    <email>j.stefaniak@gumed.edu.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Gdańsk - Departament of Anesthesiology and Intensive Care</name>
      <address>
        <city>Gdańsk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan J Stefaniak, M.D.</last_name>
      <phone>+48583493270</phone>
      <email>klanest@gumed.edu.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 9, 2019</study_first_submitted>
  <study_first_submitted_qc>April 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <last_update_submitted>April 14, 2019</last_update_submitted>
  <last_update_submitted_qc>April 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Radoslaw Owczuk</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

